+948.4%
MRNA vs GH
+214.3%
+734.1%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.2% | -2.3% | -2.2% |
| 7D | -12.7% | -3.9% | -8.8% | -11.8% |
| 30D | -20.7% | -12.5% | -8.2% | -17.8% |
| 3M | +46.3% | -13.1% | +59.4% | +52.2% |
| 6M | +305.2% | +26.8% | +278.4% | +283.7% |
| YTD | +561.2% | +42.8% | +518.5% | +503.0% |
| 1Y | +772.1% | +45.4% | +726.7% | +690.3% |
| 3Y | +147.0% | +510.2% | -363.2% | +47.3% |
| 5Y | -26.1% | +49.4% | -75.5% | -44.1% |
| All | +948.4% | +214.3% | +734.1% | +561.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GH.
Daily Out/Under-Performance
Portfolio return minus GH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling